FJA van Rooij

FJA van Rooij is an active researcher in the Department of Epidemiology at Erasmus University Medical Center, specifically affiliated with the Erasmus School of Health Policy & Management. Their work centers on large-scale genetic and cohort studies, leveraging data from initiatives like the Rotterdam Study, VA Million Veteran Program, and NHLBI Trans-Omics for Precision Medicine Consortium.

Research interests focus on genome-wide association methodologies, cardiovascular disease mechanisms, and pharmacological epidemiology. Key areas include genetic regulation of coagulation factors (fibrinogen, factor VIII), microRNA biomarkers for aging populations, and validation of data-driven approaches in antihypertensive prescription analysis. This work bridges molecular genetics with population health through multi-ethnic cohort analyses.

Recent publications demonstrate expertise in cohort study design and genetic epidemiology, with trends emphasizing translational applications of genomic data for cardiovascular risk prediction and drug utilization research. Collaborations span major international consortia including TOPMed and INVENT, highlighting integration of omics data with clinical outcomes.

No scientific awards are documented in the provided profile. Van Rooij participates in collaborative research networks without explicit mention of independent grant leadership or student supervision in the scraped content. Their work is embedded within institutional cohort studies like the Rotterdam Study, which serves as a primary data source for cardiovascular and genetic epidemiology research at Erasmus MC.